| ||||||||||||||||||||||||||||||||||||
|
:: November 2009 Welcome to our Monthly Online Newsletter!View all Treatment articles in our Treatment Report . The most recent articles are listed on top (not in alphabetical order). Click on the Topic on our home page and then the subtopic - Treatment Report. Stay updated on drugs and their side effects, and various other treatments, including exercise, nutrition, and supplements. Highlighted ArticleOmega-3 Polyunsaturated Fatty Acids and Cardiovascular Disease Protection “The current AHA guidelines recommended combined EPA and DHA in a dose of approximately 1000 mg/day in patients with CHD.17 This dose may also now be appropriate for patients with HF.1,12,14 Since few patients eat four or more oily fish meals per week, this dosage of EPA + DHA would generally require two or three OTC fish oil capsules, depending on the exact concentrations of EPA and DHA (equivalent to one Lovaza, which is not FDA-approved for this indication). In patients with elevated triglycerides, 3-5 g/day of EPA + DHA would be needed, which generally would require between 6-12 OTC fish oil capsules (or 4 Lovaza, the FDA-approved preparation). Conclusions Based on considerable evidence, the target EPA + DHA consumption should be at least 500 mg/day for individuals without overt CV diseases, and at least 800-1000 mg/day for individuals with known CHD and HF. As was recently reviewed in detail, 1 further studies are needed to determine optimal dosing and the relative ratio of DHA and EPA that provides maximal CV protection in those at risk of CV diseases, as well as in the treatment of atherosclerosis, arrhythmias, and primary myocardial disorders. However, the constellation of data suggests that this story represents a "fish tale with growing credibility."1 “ Clinical GuidelinesACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention NGC - Acute coronary syndromes. A national clinical guideline. (2006) NGC - Cardiac arrhythmias in coronary heart disease. A national clinical guideline. (2007) NGC - Chronic chest pain—suspected cardiac origin. (2006) NGC - Coronary angiography and indications for CABG or angioplasty. (2004) NGC - Coronary heart disease (CHD): symptoms, diagnosis and treatment. (2008) NGC - Diagnosis and treatment of chest pain and acute coronary syndrome (ACS). (2006) NGC - Differential diagnosis of chest pain. (2008) NGC - Gender-specific practice guidelines for coronary artery bypass surgery. (2004) NGC - Secondary prevention of coronary artery disease clinical practice guidelines. (2006) NGC - Shortness of breath--suspected cardiac origin. (2006) NGC - Stable coronary artery disease. (2006) NGC - Unstable angina pectoris. (2006) NGC - VA/DoD clinical practice guideline for management of ischemic heart disease. Internet SitesFeatured siteNIH - Medical Encyclopedia Coronary heart disease NIH - Heart Diseases--Prevention NIH - Medical Encyclopedia Coronary heart disease NIH - Pacemakers and Implantable Defibrillators Related InfoMedSearch Topics (2 selected)Related Topics - Highlighted Articles
Diet - HealthFitness - Exercise
|
|
|||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||